heart failure

Joe Jimenez

Novartis' Entresto gets more love in EU than U.S.

Novartis is seeing much faster uptake of heart failure drug Entresto in Europe as payer pushback in the U.S. on Entresto and some other new generation heart drugs are dulling sales in what is usually the best market for new meds.